These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27988509)

  • 1. Rivaroxaban-Induced Gastrointestinal Bleeding Presenting as Acute Colon Obstruction.
    Cohen M; Nevo H; Hershko D; Becker A
    Pharmacology; 2017; 99(3-4):124-127. PubMed ID: 27988509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous, Life-Threatening Hemorrhagic Cardiac Tamponade Secondary to Rivaroxaban.
    Kham NM; Song M
    Am J Ther; 2016; 23(4):e1128-31. PubMed ID: 26035030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.
    Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B
    Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
    Sherid M; Sifuentes H; Sulaiman S; Samo S; Husein H; Tupper R; Thiruvaiyaru D; Spurr C; Sridhar S
    Digestion; 2014; 90(2):137-46. PubMed ID: 25278002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of coagulation markers and 4F-PCC-mediated reversal of rivaroxaban in a rabbit model of acute bleeding.
    Herzog E; Kaspereit F; Krege W; Mueller-Cohrs J; Doerr B; Niebl P; Dickneite G
    Thromb Res; 2015 Mar; 135(3):554-60. PubMed ID: 25619440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing Subdural Bleeding Associated With Rivaroxaban: A Series of 3 Cases.
    Faust AC; Woodard S; Koehl JL; Mees W; Steinke D; Denetclaw TH
    J Pharm Pract; 2016 Jun; 29(3):257-62. PubMed ID: 26787638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare cause of GI bleeding in a patient with cutaneous vascular malformations.
    Tsoutsouki J; Laskaratos FM; Mason S; Smith M; Sinha L
    Gut; 2016 Nov; 65(11):1792. PubMed ID: 26809732
    [No Abstract]   [Full Text] [Related]  

  • 9. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal intracerebral bleeding under rivaroxaban.
    Stöllberger C; Bastovansky A; Finsterer J
    Int J Cardiol; 2015 Dec; 201():110-2. PubMed ID: 26296048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban: An Evaluation of its Cardiovascular Benefit-Risk Profile Across Indications Based on Numbers Needed to Treat or Harm, and on Clinically Meaningful Endpoint Comparisons.
    Ageno W
    Drugs R D; 2015 Dec; 15(4):295-306. PubMed ID: 26416655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
    Reddy P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
    Nairooz R; Sardar P; Pino M; Aronow WS; Sewani A; Mukherjee D; Paydak H; Maskoun W
    Int J Cardiol; 2015; 187():345-53. PubMed ID: 25839640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute Carpal Tunnel Syndrome due to Spontaneous Bleeding after Taking Rivaroxaban (Xarelto®)].
    Hohendorff B; Biber F; Sauer H; Franke J
    Handchir Mikrochir Plast Chir; 2016 Jun; 48(3):168-70. PubMed ID: 25970598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the appropriateness of dosing, indication and safety of rivaroxaban in a community hospital.
    Tellor KB; Patel S; Armbruster AL; Daly MW
    J Clin Pharm Ther; 2015 Aug; 40(4):447-51. PubMed ID: 26010016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral adrenal gland hemorrhage in a patient treated with rivaroxaban.
    Comuth W; Christiansen JJ; Bloch-Münster AM; Husted S
    Blood Coagul Fibrinolysis; 2017 Jan; 28(1):102-104. PubMed ID: 26919451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation.
    Kauffmann S; Chabanne R; Coste A; Longeras F; Sinegre T; Schmidt J; Samama CM; Constantin JM; Lebreton A
    A A Case Rep; 2015 Jun; 4(11):151-4. PubMed ID: 26035221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban: A Multicenter Evaluation.
    Pahs L; Beavers C; Schuler P
    Crit Pathw Cardiol; 2015 Jun; 14(2):53-61. PubMed ID: 26102014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing of rivaroxaban by indication: getting the right dose for the patient.
    Escolar G; Carne X; Arellano-Rodrigo E
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1665-77. PubMed ID: 26329812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
    Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
    Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.